AMOXICILLIN AND CLAVULANATE POTASSIUM by Novartis is 12. Approved for infections in adults, due to susceptible isolates of the designated bacteria in the conditions listed below: lower respiratory tract infections – caused by beta–lactamase–producing isolates of haemophilus influenzae, moraxella catarrhalis and 7 more indications. First approved in 2002.
Drug data last refreshed 17h ago
12.1 Mechanism of Action Amoxicillin and clavulanate potassium tablets, amoxicillin and clavulanate potassium for oral suspension, and amoxicillin and clavulanate potassium tablets (chewable) are antibacterial drugs [see ]. 12.3 Pharmacokinetics Mean amoxicillin and clavulanate potassium…
Worked on AMOXICILLIN AND CLAVULANATE POTASSIUM at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.